Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Corcept Therapeutics
M.D. Anderson Cancer Center
Pfizer
Pathos AI, Inc.
Stemline Therapeutics, Inc.
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Eli Lilly and Company
K36 Therapeutics, Inc.
Ensem Therapeutics
Pfizer
Massachusetts General Hospital
Eli Lilly and Company
VA Office of Research and Development
Revolution Medicines, Inc.
DL Analytics
Rutgers, The State University of New Jersey
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Intuitive Surgical
Massachusetts General Hospital
Genelux Corporation
The Netherlands Cancer Institute
University of Pittsburgh
Plus Therapeutics
Marengo Therapeutics, Inc.
Cogent Biosciences, Inc.
The First Affiliated Hospital of Guangzhou Medical University
Novartis
Endocyte
Stanford University
UroGen Pharma Ltd.
Karolinska Institutet
VA Greater Los Angeles Healthcare System
Mabwell (Shanghai) Bioscience Co., Ltd.
OncoSil Medical Limited
Taipei Veterans General Hospital, Taiwan
Nanfang Hospital, Southern Medical University
University of Cologne
Sociedad Española de Medicina Nuclear e Imagen Molecular
Jiangxi Provincial Cancer Hospital
Concure Oncology-Breast Microseed Inc.